in this issue
Regions :: Western Europe :: U.K.
'Patent Box' Legislation Attracts GSK to Invest $776 Million in U.K.
9:03 AM MST | November 30, 2010 | Alex Scott
Legislation proposed this week by the U.K. government to encourage the development of intellectual property (IP) and manufacturing in the U.K. has led GlaxoSmithKline (GSK) to announce a £500 million ($776 million) investment in R&D and manufacturing in the country. GSK’s package of planned investments features a £50 million U.K. venture capital fund for early stage healthcare companies and university spin outs; formation of a green chemistry academy at the University of Nottingham (Nottingham, U.K.); additional investment in...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee